• Skip to content
  • Skip to primary sidebar
  • Skip to footer
847-752-5355 info@avfmail.org
  • Facebook
  • LinkedIn
  • Twitter
  • News
  • Contact Us
  • Member Portal

Vein Forum

Promoting venous and lymphatic health

  • About
    • President’s Message
    • Leadership & Committees
    • ByLaws
      • AVF ByLaws
      • AVFF ByLaws
    • Awards & Recognition
      • Servier Traveling Fellowship
      • American Venous Forum Founder’s Award
      • BSN-Jobst Research Grant in Venous and Lymphatic Disease
      • Distinguished Fellow Members
    • Find a Doctor
  • Membership
    • AVF Membership Information
    • Become a Member
    • Renew Your Membership
  • CME Education
    • 2019 AVF Annual Meeting
    • Upcoming Meetings
    • Past Meetings
    • Other Meetings and Education
  • Resources
    • AVF Initiatives
    • Clinical Practice Guidelines
    • Handbook of Venous Disorders
    • News & Publications
    • Practice Resources
    • Research
    • Vein Specialist Journal
  • For Patients
    • Video Library
    • What is Vein Disease?
      • What is Deep Vein Thrombosis?
      • What is Pulmonary Embolism?
      • What is Chronic Venous Disease?
      • What is Lymphedema?
      • What is Compression Therapy?
    • Vein Handbook
    • Screening
      • Screening Locations
      • Online Screening
    • The Radio Talk Show Program: Healthy Veins, Healthy Legs
  • AVF Foundation
    • 2019 Venous Open Golf & Tennis
    • Our Impact
    • Board of Directors
    • Partners and Sponsors
    • BSN-JOBST Research Grant
    • Contact Us
  • Donate

American Venous Forum

AVF Member Pledge

February 6, 2019 By Curtis Ksenak

Membership Pledge of the American Venous Forum:

As a condition of membership in the American Venous Forum, I pledge:

  • To practice evidence based venous and lymphatic medicine and/or surgery with integrity, courtesy, and compassion.
  • To provide appropriate care in the best interest of my patients
  • To treat all without bias.  
  • To maintain confidentiality in my patient and professional interactions.
  • To collaborate, cooperate and respect my professional colleagues.
  • To participate in scientific knowledge and continuing medical education in the art and science of venous and lymphatic practice.
  • To provide accurate information without purposeful misrepresentation concerning venous and lymphatic disease to my patients and the public.
  • I make this pledge freely and upon my honor.

AVF Principles of Ethics

Members of the American Venous Forum are committed to observing and promoting the highest standards of ethical conduct in their professional affairs.  

The ideals and principles of the American Venous Forum should guide the conduct of those who belong.   These ideals and principles are listed below and they are affirmed by the Membership Pledge of the American Venous Forum.

Accountability

· Faithfully abide by the Articles of Incorporation, bylaws and policies of the organization as a full active member.

· Exercise reasonable care, good faith and due diligence in governing and managing affairs.

· Fully disclose, at the earliest opportunity, information that may result in a perceived or actual conflict of interest when engaging in endeavors such as research or presentations relating to the AVF (See Section on Conflict of Interest).

Professional Excellence – Integrity

· Maintain a professional level of courtesy, respect, and objectivity in all matters and activities in your practice and within the AVF.

· Strive to uphold those practices and assist other members of the AVF in upholding the highest standards of conduct.

Personal Gain – Self-Dealing

· Exercise the powers invested for the good of all members of the AVF organization and the venous and lymphatic medical community rather than for personal benefit.

Equal Opportunity – Diversity – Inclusivity

· Ensure the right of all members to access benefits and services without discrimination on the basis of culture, geography, political, religious, socio-economic aspects. sexual orientation, national origin, race, religion, age, political affiliation or disability, in accordance with all applicable legal and regulatory requirements.

Confidential Information

· Respect the confidentiality of sensitive information known to AVF members and used for the purposes of governance and management.

Collaboration and Cooperation

· Respect the diversity of opinions as expressed or acted upon by the committees and the AVF membership, and formally register dissent as appropriate.

Filed Under: American Venous Forum

AVF and AVFF Welcomes Veritas Meeting Solutions as New Management Company

November 2, 2018 By Curtis Ksenak

Dear Members of the AVF,

I am pleased to announce that effective November 1, 2018, the Board of Directors of the AVF has put in place a new administration to provide much needed administrative support for our members and organization. After a highly competitive search process, Veritas Meeting Solutions (Veritas), a Chicago-based association management company, has been selected to provide management services and administrative support for the AVF and the AVFF.

Founded in 2013 by industry professionals, Sue O’Sullivan and Donna Kelly, each with nearly two decades of association management experience, Veritas is completely dedicated to managing non-profit medical associations and continuing medical education meetings for academic institutions. Currently, Veritas is providing management services to 18 medical sub-specialties and 10 academic institutions. Client organizations include: radiologists, urologists, endocrinologists, robotic surgeons, plastic surgeons, otolaryngologists, pediatricians and now vascular surgeons. With a full time staff of 19 dedicated and highly talented professionals, Veritas has the breadth and depth of experience as well as the infrastructure to support the growing needs of the AVF.

I am personally thrilled with the selection of Veritas as our management service provider and believe the AVF and AVFF are in good hands administratively. Should you need information about AVF activities or resources to support your practice, please feel free to contact the AVF Membership Team at 847-752-5355.

In addition to selecting Veritas as our management services provider, your Board has hired John Forbes as the Interim Executive Director of the AVF. John brings a wealth of experience to the AVF having served in similar leadership roles with the American Academy of Periodontology, the American Academy of Pediatrics and the American Red Cross. John has been asked to provide executive leadership of the AVF until a permanent Executive Director is selected and can be reached at john@balancedgrowth.com.

Finally, both the Board of the AVF and AVFF are thrilled to have the continued service of Jeffrey Mendola, Director of Mission Advancement for our foundation, the AVFF. Jeff plays a critical leadership role as our main point of contact with industry and has been instrumental in bringing much needed, mission-advancing resources to our organizations. He can be reached at jeffrey@www.veinforum.org.

I would like to thank you for all you do to help patients afflicted with vascular disease and for your membership in the AVF. I am proud and honored to serve as your president and hope to see you at our upcoming Annual Meeting in Rancho Mirage, California from February 19-22, 2019.

With Appreciation,

Elna Masuda
President
American Venous Forum

Filed Under: American Venous Forum

Asian Venous Forum Welcomes the American Venous Forum

August 22, 2018 By Curtis Ksenak

The 13th Annual Meeting of the Asian Venous Forum was held in Guangzhou, China on July 12-15 together with the 19th Congress of the Asian Society for Vascular Surgery (ASVS).

Dr Peter Gloviczki from the Mayo Clinic and Past President of the American Venous Forum delivered a keynote address on venous reconstructions.  Peter, Editor of the 4th Edition of the “Handbook of Venous and Lymphatic Disorders, Guidelines of the American Venous Forum”, presented Professor Shenming Wang, Chair of the Congress, with a copy of the book, after his address.

Invited lectures by AVF members from around the world included Peter F. Lawrence, Monika L. Gloviczki, Manju Kalra, Sergio Gianesini, Andrew Bradbury, Evi Kalodiki, Christopher Lattimer, and Neil Khilnani.

There were animated discussions at the joint meeting of the Journal of Vascular Surgery Publications and the Annales of Vascular Diseases (AVD) – the official journal of the ASVS.  AVD Editor Tetsuro Miyata and JVS/JVS-Venous and Lymphatic Disorders Editors Peter Gloviczki and Peter Lawrence engaged in lively discussion with great audience participation.

The next combined meeting of the ASVS and Asian Venous Forum will be held in beautiful Bali, Indonesia, on 22 – 26 October 2019.  https://asvs2019.com/

Filed Under: American Venous Forum

American Venous Forum and CMS Meet to Discuss Inconsistent LCD’s

July 30, 2018 By Curtis Ksenak

Earlier this year, the American Venous Forum and AVF Foundation adopted “Healthy Veins for Healthy Life.”  One of our 4 strategic “Healthy Veins” initiatives is to Advocate for Access.  Two objectives of this initiative are to:

  • Promote evidence-based best practices to ensure that all patients have access to the highest quality care. This includes access for all patients, regardless of where they choose to live.
  • Become point society for questions from the FDA, CMS, 3rd party payers, RUC and MEDCAC. The AVF would be an optimal clearing house for insurance and government issues.

On 7/24/18, the American Venous Forum took another step forward in support of these goals.

Under the direction of the Health Policy committee chairs,  Fedor Lurie and Kathleen Ozsvath, and AVF leadership BK Lal (President-Elect), Hal Welch (Vice-President), and Elna Masuda (President), the AVF group met with the Coverage and Analysis Group (CAG) of the Centers for Medicare and Medicaid of the Department of Health and Human Services at the CMS headquarters in Baltimore.

Representing CMS were Tamara Syrek Jensen (Group Director, CAG), Joseph Chin (Deputy Group Director, CAG), Lori Ashby (Division Director-Division of Policy and Evidence Review), Marie Casey (Program Management Officer, CAG), Jyme Schafer (Medical Officer, CAG) and David Dolan (Analyst, CAG).

This was not our first meeting with CMS.  The AVF met with CMS in April of 2016 and May of 2017.  AVF representatives also participated in CMS meetings with the Wound Care Alliance in November of 2015 and January of 2016.

This meeting focused on the issue of inconsistent local coverage determination and opportunities to harmonize reimbursement policies for the treatment of patients with venous disease across the nation.

The actions taken following our CMS meeting a year ago and their results were discussed.  We also talked about opportunities to collaborate in addressing remaining obstacles and new challenges for securing and maintaining patients’ access to appropriate care.

The meeting featured extremely friendly conversations, a complete reversal on the NCD issue, an openness to the idea of a disease-targeted NCD, and a willingness to work together closely in the future.

This productive meeting resulted in a plan of action that will be refined and serve as the basis for increasingly close collaboration between the American Venous Forum and the CMS.

Healthy Veins for Healthy LifeTogether with CMS, the American Venous Forum has taken another large step forward in pursuit of “Healthy Veins for Healthy Life.”

Filed Under: American Venous Forum

Primary Sidebar

Recent Posts

  • AVF Member Pledge
  • AVF and AVFF Welcomes Veritas Meeting Solutions as New Management Company
  • Asian Venous Forum Welcomes the American Venous Forum
  • American Venous Forum and CMS Meet to Discuss Inconsistent LCD’s

Categories

  • American Venous Forum

Archives

  • February 2019
  • November 2018
  • August 2018
  • July 2018

Learn about American Venous Forum Foundation

Improving health care of patients with venous and lymphatic disorders through awareness, education and innovative research.

Learn about the AVF Foundation

Become a Member

Apply for membership

To Make a Charitable Donation

Click here to make a donation

Footer

American Venous Forum
American Venous Forum Foundation

1061 E. Main Street
Suite 300
East Dundee, IL 60118
847-752-5355

Proudly Managed by Veritas Meeting Solutions
  • Facebook
  • LinkedIn
  • Twitter

Useful Links

  • About Us
  • Medical & Allied Health Professionals
  • For Patients
  • American Venous Forum Foundation
  • Member Portal

Quick Links

  • Contact Us
  • Privacy Policy
  • Legal / Terms of Use
  • Sitemap
  • News
  • Member Portal

Copyright © 2019 American Venous Forum

Chapter 20: Lymphedema Diagnosis and Therapy

Original authors: Audrea Cheville, Cindy Felty, Gail L. Gamble, Peter Gloviczki, Thom W. Rooke, David Strick

Abstracted by Raghu Motaganahalli

Content:

  • Introduction
  • Lymphatic system
  • Types of lymphedema
    • Primary lymphedema
    • Secondary lymphedema
    • Symptoms of lymphedema
    • Diagnosis of lymphedema
    • Medical treatment of lymphedema
    • Surgical treatments for lymphedema
  • Commonly asked questions
    • What is lymphedema?
    • What can cause lymphedema?
    • What I do if I have lymphedema?
    • Is surgery for lymphedema a good option?

Summary:

Lymphedema is swelling in the leg, arm or other parts of the body due to the body’s inability to effectively remove lymph fluid (which contains proteins, fatty acids, waste from cell feeding and bacteria that enter the body). Lymphedema can happen because the formation of the lymph vessels during maturation was less than adequate (called primary lymphedema) or damage (injury) has occurred to the normally formed lymph channels and lymph nodes during surgery, from infection, from radiation treatment or other causes. It can also occur from too much lymph fluid being made such as can happen when venous disease is present. Before treating lymphedema itself a physician has to be sure that there is no infectious or other acute medical problem that must be dealt with. The most important medical therapy used for lymphedema is external compression treatments (massage, compression pumping, compression wraps and eventually compression stockings) to decrease the swelling and to keep it down. Surgery for lymphedema is a last option for only a select group of patients.

Open Chapter 20 (PDF Format)

Chapter 19: Vascular Malformations

Original authors: David H. Deaton, Byung Boong Lee, James Loredo, Richard F. Neville, William H. Pearce, and Heron E. Rodriguez

Abstracted by Raghu Motaganahalli

Content:

  • Introduction
  • Hemangioma
  • Congenital vascular malformations (venous malformations emphasis)
    • Overview
    • Vascular Malformations which stop maturing later in pregnancy
    • Vascular Malformationswhich stop maturing early in pregnancy
    • Complex Venous Malformations
      • Maffucci syndrome
      • Proteus syndrome
      • Klippel-Trenaunay syndrome
      • Parkes Weber syndrome
  • Conclusions
  • Commonly asked questions
    • My child has a reddish spongy mass on the cheek, what should I do?
    • My doctor thinks that my baby had a congenital venous malformation, what does this mean?
    • My seven year old hasa birth mark on the left leg and back, a varicose vein that I just noticed that goes down the outside of the leg, and his leg on that side may be a little bigger than the other side.  What could be the problem?
    • My child has a congenital venous malformation, are we at risk for other children with the same problem?

Summary:

A hemangioma, commonly known as a “strawberry birthmark”,  is the most common benign tumor of infancy.  These vascular tumors grow very fast during the first year of life to the fear of the parents but then stop growing and actually get smaller very slowly during childhood so that they are usually gone by school age.  Only in rare cases is any treatment needed. Congenital vascular malformations are the result of blood vessels not maturing (going to full development) while the infant is still in the mother’s womb.  If this happens early, the abnormal blood vessels do not have the form usually seen with blood vessels and appears more like a spongy mass which can involve neighboring body parts.  If this happens later in the pregnancy, the blood vessels look more normal but are abnormally small, abnormally large or have unusually connections with other blood vessels. As a part of congenital vascular malformations, the venous malformation is the most common and possibly the easiest to manage. Congenital vascular malformations do not go away and will require a lifetime of care.

Open Chapter 19 (PDF Format)

Chapter 18: Iliac and Vena Cava Obstructive Venous Disease Therapy

Original author: Peter Neglén

Abstracted by Gary W. Lemmon

Content:

  • Diagnosis
  • Therapy
  • Conclusions
  • Commonly asked questions
    • Will treating iliac vein narrowing I have heal my leg ulcer?
    • What are the stents made of and can I feel them?

Summary:

Iliac vein or vena cava vein blockage or narrowing prevents blood flow from getting out of the leg(s) since these are the major exit sites for this blood to get back to the heart.  Removing blockages from these veins is possible with techniques that allow one to place a dilating balloon and stent (metallic support device) inside the narrowed vein. In the rare case that this is not successful, there are surgical procedures which can help.

Open Chapter 18 (PDF Format)

Chapter 17: Surgical Therapy for Deep Valve Incompetence

Original authors: Seshadri Raju

Abstracted by Gary W. Lemmon

Content:

  • Introduction
  • Diagnosis
  • Surgical options
  • Complications
  • Results
  • Conclusions
  • Commonly asked questions
    • When such I ask my doctor about deep vein valve surgery?
    • How long will I need to be on Warfarin treatment?
    • What happens to the arm if the vein is taken from that location to be transplanted to the leg veins?

Summary:

Vein valves that do not work will cause blood to flow backward in the veins into the legs.  This leads to problems with swelling, skin changes and even breakdown of the skin (ulcers).  There are ways to stop this abnormal backward flow of blood by fixing the vein valves.  If the valve is still present but just not meeting properly, the valve can be fixed with fine sutures.  If the valve is totally damaged, one must place the refluxing system below a working valve in another part of the leg veins (transposition) or must take one from the arm as a transplant. Other techniques are being investigated but so far these are the more common ways to fix the problem.

Open Chapter 17 (PDF Format)

Chapter 16: Surgical Therapy for Chronic Venous Insufficiency

Original authors: Alun H. Davies, Adam Howard, Dominic P.J. Howard, Lowell S. Kabnick, Robert L. Kistner, Robert F. Merchant, Nick Morrison

Abstracted by Gary W. Lemmon

Content:

  • Introduction
  • Definitions
  • Economics of Chronic Venous Insufficiency
  • Presentation
  • Examination
  • Management
  • Vein stripping
  • Vein ablation
  • Complications
  • Conclusions
  • Commonly asked questions
    • I have varicose veins. Do I need these to be treated?
    • Are stockings necessary to wear for CVI or varicose veins?
    • Which is better, vein stripping or “laser” surgery?
    • Are varicose veins hereditary?

Summary:

The superficial leg veins can allow the backward flow of blood down the veins and result in lower leg swelling, skin changes and even skin breakdown (ulcers). By removing these non-working veins, the symptoms are made better. One can remove these veins from the body by pulling them out (stripping) or by burning the inside so that they scar shut (laser or radiowave ablation, or sclerotherapy). The patient must know that there can be problems with each method of removal and must believe that the benefits are better than the risks involved.

Open Chapter 16 (PDF Format)

Chapter 15: Sclerotherapy for Venous Disease

Original authors:  Niren Angle, John J. Bergan, Joshua I. Greenberg,  and J. Leonel Villavicencio

Abstracted by Teresa L. Carman

Content:

  • Introduction
  • Indications (reasons) for using sclerotherapy
  • Contraindications (reasons not to use) to sclerotherapy
  • How is sclerotherapy performed?
  • Complications (problems) of sclerotherapy
  • Foam Sclerotherapy
  • Commonly asked questions
    • Do I need surgery for my veins?
    • Will I need only one treatment or more?
    • Will my insurance pay for this therapy?
    • How long will I be off work after the procedure?

Summary:

The information provided here is to serve as a guideline regarding one possible treatment (sclerotherapy) and what to expect. Therapy is very individualized to a single patient and the best treatment options for your condition should be discuss with physicians skilled in the evaluation and treatment of vein problems. Most patients will require several sclerotherapy treatments to fully treat their venous disease and may have veins return over a period of time requiring further therapy.

Open Chapter 15 (PDF Format)

Chapter 14: Spider Veins/Telangiectasias Therapy

Original authors: Jose I. Almeida,  Thomas M. Proebstle and Jeffrey K. Raines

Abstracted by Michael C. Dalsing.

Content:

  • Introduction
  • Etiology and Diagnosis
  • Treatment and Results
  • Conclusions
  • Commonly asked questions
    • What are spider veins?
    • What causes spider veins?
    • Are there ways to get rid of my spider veins?

Summary:

Spider veins are very small blemishes within the skin. The cause of the spider veins must be sought and treated prior to taking care of the skin blemish. To eliminate the spider veins, currently two treatments are commonly used; Laser treatment uses light to heat the spider vein resulting in scarring while sclerotherapy uses drugs to damage the inside of the vein resulting in scarring. Each method has risks including a worsened cosmetic appearance for the potential benefit of eliminating the blemish.

Open Chapter 14 (PDF Format)

Chapter 13: Compression Therapy for Venous Disorders and Venous Ulceration

Original authors:  Gregory L. Moneta and Hugo Partsch

Abstracted by Teresa L. Carman

Content:

  • Introduction
  • Physiology
  • Diagnosis
  • Forms of compression
  • Conclusions
  • Commonly asked questions
    • Compression stockings are hard to get on. Do I have to wear them every day?
    • How can I make the compression stockings easier to put on?
    • Which stocking is the best?

Summary:

The abnormal backward flow of blood in the leg veins or blockages to the blood getting out of the leg can lead to problem including swelling, skin changes and even ulcers. Once the diagnosis is made, placing compression from the outside of the leg can correct many of the underlying problems such that the symptoms get better.  Compression therapy comes in many forms and some devices are better for healing ulcers (open skin lesions) and other for maintaining a steady state within the leg.

Open Chapter 13 (PDF Format)

Chapter 12: Chronic Venous Insufficiency Presentation

Original authors: Andrew W. Bradbury, Andrew D. Lambert, Robert B. McLafferty, and C. Vaughan Ruckley

Abstracted  by Teresa L. Carman

Content:

  • Introduction
  • Incidence
  • Presentation
  • Diagnosis
  • Conclusions
  • Commonly asked questions
    • Do I need to bring anything to my first appointment with the vein specialist?
    • Do I need to fast or not eat before my appointment?
    • Will I need a surgery for my veins?

Summary:

Evaluation of venous disease whether asymptomatic or causing severe symptoms begins with a good history and a physical examination including laboratory studies if necessary. Most venous disease is not a major problem for the patient and does not require a surgery or procedure. Patients with bothersome symptoms or recurrent ulcers may benefit from a procedure or surgery.

Open Chapter 12 (PDF Format)

Chapter 11: Physiology of Venous Insufficiency

Original authors: Kevin G. Burnand and Ashar Wadoodi

Abstracted by Teresa L. Carman

Content:

  • Introduction
  • Chronic Venous Insufficiency
  • Chronic Vein Insufficiency Effects
  • Commonly asked questions
    • Why do my legs swell?
    • What if my swelling just happened and is only in one leg?
    • What causes the veins to not work well?
    • What can I do about my swelling and what can happen if I do nothing?

Summary:

Two other major contributors to venous insufficiency are venous reflux and venous obstruction. Regardless of the cause, chronic venous insufficiency and chronic venous hypertension may result in leg swelling, skin darkening or hyperpigmentation, skin thickening or lipodermatosclerosis (fat and skin scar development), and even sores or ulcers. Your doctor can do laboratory testing and vascular testing to determine what conditions you may have.

Open Chapter 11 (PDF Format)

Chapter 10: Axillary/Subclavian Vein Thrombosis (clot) and its Treatment

Original authors: Richard M. Green and Robert Rosen

Abstracted by Gary W. Lemmon

Content:

  • Introduction
  • Diagnosis
  • Management
  • Conclusion
  • Commonly asked questions
    • What is thoracic outlet syndrome and who can be affected by it?
    • Can both arms be involved?
    • What type of disability remains with treatment?

Summary:

Axillo-subclavian vein thrombosis occurs as a result of abnormal muscle and/or rib anomalies of the thoracic outlet at the base of the neck and ribcage. Treatment should be done rapidly and involves three steps which includes dissolving the clot, maintaining anticoagulation (stopping any new clots from forming) with a blood thinner and surgical treatment to eliminate the external compression on the subclavian vein.

Open Chapter 10 (PDF Format)

Chapter 9: Indications for Inferior Vena Cava Interruption

Original authors: Lazar J. Greenfield, Venkataramu N. Krishnamurthy, Mary C. Proctor, and John E. Rectenwald

Abstracted by Gary W. Lemmon

Content:

  • Introduction
  • Surgical treatment advances
  • Conclusion
  • Commonly asked questions
    • Is it safe to leave the filter in and does it has to stay there for my lifetime?
    • Can the filter be placed for blood clots in the arms rather than the legs?
    • With so many filter types which one is the best for me?

Summary:

Blood clots from the large veins of the legs and pelvis can produce life threatening Pulmonary Embolism (PE) if left untreated such as when standard therapy cannot be used. PE management might include placement of an inferior vena cava filter effective in preventing PE. However filter does not reduce the risk to zero nor does it treat the underlying venous clotting problem. Therefore continued anticoagulant therapy (blood thinners) should be used when possible.

Open Chapter 9 (PDF Format)

Chapter 8: Surgical/Interventional Treatment of Acute Deep Venous Thrombosis

Original authors: Anthony Comerota, Bo Eklof, Jorge L. Martinez, and Robert B. McLafferty

Abstracted by Michael C. Dalsing

Content:

  • Introduction
  • Why remove acute blood clot? Goals of treatment
  • Ways (method) of removing acute blood clot
  • Venous narrowing (stenosis) may be seen as one cause of the blood clot
  • Risks connected to removing acute blood clot
  • Expected results
  • Conclusion
  • Commonly asked questions
    • What is thrombolysis?
    • Which patients derive the most benefit from catheter-directed thrombolysis?
    • What are the objectives of thrombolysis or surgical thrombectomy?
    • Are there other benefits of catheter-directed thrombolysis or surgical thrombectomy?
    • What are the risks of using thrombolysis to remove free blood clot?
    • Are there alternatives to catheter-directed thrombolysis for extensive venous thrombosis?
    • Why are blood thinner used after thrombolysis or surgical thrombectomy?

Summary:

There are several interventional treatment options for acute deep venous thrombosis (DVT): catheter-directed thrombolysis with or without mechanical device use is the preferred treatment option for patients with iliofemoral deep venous thrombosis who are otherwise healthy and have no contraindication to receiving a thrombolytic drug. If thrombolysis is too high a risk, venous thrombectomy is recommended. For patients who are bedridden and those who are in very poor health, treatment with anticoagulation agents (blood-thinning agents) alone may be advisable. Successful and timely clot removal in patients with iliofemoral DVT results is less post-thrombotic symptoms and an improved health-related quality of life.

Open Chapter 8 (PDF Format)

Chapter 7: Medical treatment of Deep Vein Thrombosis and Pulmonary Embolus

Original authors: Russell D. Hull, Graham F. Pineo, and Thomas W. Wakefield

Abstracted by Kellie R. Brown

Content:

  • Introduction
  • Goals of treatment (why treat a DVT or PE)?
  • How is a DVT or PE treated?
  • What if blood thinners can’t be used?
  • Is there anything else that can be done to help the symptoms?
  • What if the DVT is in the arm?

Summary:

DVT and PE are treated essentially the same. In this chapter you will discover what is the treatment’s strategy using heparin (often LMWH) and warfarin. In the case of a recurrent event, warfarin may be continued for life. If blood thinners aren’t able to be used, a filter can be placed to prevent the clot from traveling to the lungs. If symptoms are very severe, removal of the clot from the vein, usually by thrombolysis, can be undertaken.

Open Chapter 7 (PDF Format)

Chapter 6: Clinical Presentation of Venous Thrombosis "Clots": Deep Venous Thrombosis and Pulmonary Embolus

Original authors: Daniel Kim, Kellie Krallman, Joan Lohr, and Mark H. Meissner

Abstracted by Kellie R. Brown

Content:

  • Introduction
  • What are the most common signs and symptoms of a Deep Venous Thrombosis (DVT)?
  • What are the most common signs and symptoms of a Pulmonary Embolus (PE)?
  • How is a DVT diagnosed?
  • How is a PE diagnosed?
  • Conclusion

Summary:

The most common symptoms of DVT are pain and swelling, but many DVTs have no symptoms. The most common symptoms of PE are sudden onset of chest pain and shortness of breath. A low threshold to get further tests is needed in order to diagnose most DVTs because the symptoms are vague. DVT is usually diagnosed with ultrasound, and PE is usually diagnosed with CT scan, but other tests may be needed to make the diagnosis.

Open Chapter 6 (PDF Format)

Chapter 5: Superficial Venous Thrombosis

Original authors: Anil P. Hingorani and Enrico Ascher

Abstracted by Gary W. Lemon

Content:

  • Clinical Presentation/Diagnosis
  • Etiology
  • Treatment
  • Conclusion
  • Commonly asked questions:
    • What is superficial venous thrombosis?
    • How do I know if I have superficial venous thrombosis?
    • What is the treatment of superficial venous thrombosis?

Summary:

Most cases of Superficial Venous Thrombosis are not noticed or taken seriously by the patient and often get better without treatment. It is important however to make sure that the patient does not have a condition which is causing more than normal blood clotting (hypercoagulable states) or has an unknown cancer. In this chapter you will learn about the diagnostic tests and treatment’s options for the Superficial Venous Thrombosis.

Open Chapter 5 (PDF Format)

Chapter 4: Deep Venous Thrombosis Prevention

Original authors: Robert D. McBane and John A. Heit

Abstracted by Kellie R. Brown

Content:

  • Introduction
  • Risk Factors
  • Prevention of DVT and PE : “Mechanical” and”pharmacologic” prevention
  • Who should get preventative treatment
    • Low Risk Patients
    • Moderate Risk Patients
    • High Risk Patients
    • Very High Risk Patients
    • Non-Surgical High Risk Patients
  • Are there special circumstances that change the risk of DVT?
  • Hip or Knee Replacement Surgery
  • Neurosurgery
  • Trauma
  • How long should preventative measures be given?
  • Conclusion

Summary:

Venous thromboembolism (VTE), which is either deep vein thrombosis (DVT) or pulmonary embolus (PE), is the 4th leading cause of death in Western society.  Thus, preventing VTE is very important.  This chapter will discuss the main ways to prevent a DVT or PE.

Open Chapter 4 (PDF Format)

Chapter 3: Clotting Disorders

Original authors: Edith A. Nutescu, Jessica B. Michaud, Joseph A. Caprini, Louis W. Biegler, and Robert R. McCormick

Abstracted by Kellie R. Brown

Content:

  • Introduction
  • What is a D-Dimer Level?
  • Clotting Disorders
  • Hereditary Clotting Disorders
  • Group 1: A lack of anti-clotting factors in the blood
    • Antithrombin Deficiency
    • Protein C Deficiency
    • Protein S Deficiency
  • Group 2:  An increased amount of pro-clotting factors in the blood
    • Activated Protein C Resistance/Factor V LeidenMutation
    • Prothrombin Defects; Prothrombin Gene 20210A Mutation
    • Factor Elevations: Elevations in the levels of different proteins in the blood that participate in the clotting process
    • Hyperhomocysteinemia
  • Other Inherited Clotting Disorders
    • AntiPhospholipidantibody Syndrome (APS)
    • How common is it?
    • How and when do you test for this?
    • What is the risk of VTE in people with APS?
    • How do you treat APS?
  • Heparin Induced Thrombocytopenia
    • Heparin induced thrombocytopenia (HIT)
    • How common is HIT?
    • How and when do you test for HIT?
    • What is the risk of VTE in a person with HIT?
    • How do you treat HIT?
  • Cancer
  • Conclusion

Summary:

The normal balance between clot formation and breakdown can be changed by the presence of certain genetic or acquired defects leading to abnormal clot formation.  In this chapter you will learn about different factors that can increase the risk of VTE.  These conditions should be looked for in any person who has a VTE, unless the cause is already known.

Open Chapter 3 (PDF Format)

Chapter 2: Risk Factors for Venous Thrombosis

Original authors: Peter K. Henke, Mark H. Meissner and Thomas
W.Wakefield

Abstracted by Kellie R. Brown

Content:

  • Introduction
  • How common are Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)?
  • What causes DVT and PE (venous thromboembolism -VTE)?
  • What are the risk factors for VTE?
    • Age, Gender and Race
    • Surgery
    • Trauma
    • Medical Illness
    • Immobilization or Travel
  • Primary Blood Clotting Disorders
  • Oral Contraceptives and Hormonal Therapy
  • Pregnancy
  • How does clot affect the vein?
  • Does the vein return to normal after the clot resolves?
  • Conclusion

Summary:

This chapter will discuss the common risk factors for Deep Vein Thrombosis (DVT: blood clots forming in the deep veins often of the leg, pelvic or abdomen but can also occur in the arm veins), the changes that occur in a vein after a clot has formed, and what happens to the clot over time. Among patients with DVT, one third of them are diagnosed due to a pulmonary embolus (PE), a blood clot traveling in the blood vessels to the lung, causing shortness of breath and chest pain.  The long-term effects of DVT, called post-thrombotic syndrome (PTS), can be associated with skin discoloration, ulceration and other skin changes in the legs.

Open Chapter 2 (PDF Format)

Chapter 1: Normal Venous Circulation

Original author: Frank Padberg

Abstracted by Teresa L.Carman

Content:

  • Introduction
  • Physiology/Hemodynamics
  • Conclusion
  • Commonly asked questions:
    • Why do my legs swell?
    • What if my swelling is only in one leg?
    • What causes the veins to not work well?
    • What can I do about my swelling?

Summary: This chapter will tell you how blood flow circulates in the blood vessels called arteries from heart to the legs and back to the heart through the veins, blood vessels that return the nutritionally depleted blood. You will learn about normal venous return and abnormal venous function, which may result in swelling or edema and skin damage such a discoloration, darkening, thickening and ulceration.

Open Chapter 1 (PDF Format)

Index of chapters and authors
  1. Normal Venous Circulation:    Adapted from Chapter 3 of the “Handbook of Venous Disorders”.
    Original author: Frank Padberg.  Abstracted by Teresa L. Carman.
  2. Risk Factors for Venous Thrombosis: Adapted from Chapters 8 and 9 of the “Handbook of Venous Disorders”. Original authors: for Chapter 8 – ThomasW. Wakefield and Peter K. Henke, for Chapter 9 – Mark H. Meissner. Abstracted by Kellie R. Brown.
  3. Clotting Disorders: Adapted from Chapter 11 of the “Handbook of Venous Disorders”. Original authors: Edith A. Nutescu, Jessica B. Michaud, Joseph A. Caprini, Louis W. Biegler, and Robert R. McCormick. Abstracted by Kellie R. Brown.
  4. DVT Prevention: Adapted from Chapter 23 of the “Handbook of Venous Disorders”. Original authors: Robert D. McBane and John A. Heit. Abstracted by Kellie R. Brown.
  5. Superficial Venous Thrombosis:Adapted from Chapter 26 of the “Handbook of Venous Disorders”. Original authors: Anil Hingorani and Enrico Ascher. Abstracted by Gary W. Lemmon.
  6. Clinical Presentation of Venous Thrombosis “Clots”: Deep Venous Thrombosis and Pulmonary Embolus: Adapted from Chapters 17 and 18 of the “Handbook of Venous Disorders”. Original authors: for Chapter 17 – Mark H. Meissner and for Chapter 18 – Joann Lohr, Daniel Kim and Kellie Krallman. Abstracted by Kellie R. Brown.
  7. Medical Treatment of DVT and PE: Adapted from Chapters 19 and 22 of the “Handbook of Venous Disorders”. Original authors: for Chapter 19 – Russell D. Hull and Graham F. Pineo and for Chapter 22 – Thomas W. Wakefield. Abstracted by Kellie R. Brown.
  8. Surgical/Interventional Treatment of Acute Deep Venous Thrombosis: Adapted from Chapter 20 and 21 of the “Handbook of venous Disorders”. Original authors: for Chapter 20 – Anthony Comerota and Jorge L. Martinez Trabal and for Chapter 21 – Bo Eklof and Robert B. McLafferty. Abstracted by Michael C. Dalsing.
  9. Indications for Inferior Vena Cava Interruption: Adapted from Chapter 25 of the “Handbook of Venous Disorders”.Original authors: Lazar J.Greenfield, Venkataramu N. Krishnamurthy, Mary C. Proctor and John E. Rectenwald. Abstracted by Gary W. Lemmon.
  10. Axillary/Subclavian Vein Thrombosis (Clot) and Its Treatment: Adapted from Chapter 24 of the “Handbook of Venous Disorders”. Original authors: Richard M. Green and Robert Rosen. Abstracted by Gary W. Lemmon.
  11. Physiology of Venous Insufficiency:Adapted from Chapter 5 of the “Handbook of Venous Disorders”. Original authors: Kevin G. Burnand and Ashar Wadoodi. Abstracted by Teresa L. Carman.
  12. Chronic Venous Insufficiency Presentation: Adapted form Chapter 28 & 29 of the “Handbook of Venous Disorders”. Original authors: for Chapter 28 – Andrew W. Bradbury and C. Vaughan Ruckley and for Chapter 29 – Robert B. McLafferty and Andrew D. Lambert. Abstracted by Teresa L. Carman.
  13. Compression Therapy for Venous Disorders and Venous Ulceration: Adapted from Chapter 30 of the “Handbook of Venous Disorders”.Original authors: Gregory L. Moneta and Hugo Partsch. Abstracted by Teresa L. Carman.
  14. Spider Veins/Telangiectasias Therapy: Adapted from Chapter 34 and 39 of the “Handbook of Venous Disorders”. Original authors: for Chapter 34 – Thomas M. Proebstle and for Chapter 39 – Jose I. Almeida and Jeffrey K. Raines. Abstracted by Michael C. Dalsing.
  15. Sclerotherapy for Venous Disease: Adapted from Chapter 32 and 33 of the “Handbook of Venous Disorders”. Original authors: for Chapter 32 – J. Leonel Villavicencio and for Chapter 33 – Joshua I. Greenberg, Niren Angle and John J. Bergan. Abstracted by Teresa L. Carman.
  16. Surgical Therapy for Superficial ChronicVenous Insufficiency: Adapted from Chapters 35, 36, 37 and 38 of the “Handbook of Venous Disorders”. Original authors: for Chapter 35 – Adam Howard, Dominic P.J. Howard and Alun H. Davies; for Chapter 36 – Robert F. Merchant and Robert L. Kistner; for Chapter37 – Nick Morrison and for Chapter 38 -Lowell S. Kabnick. Abstracted by Gary W. Lemmon.
  17. Surgical Therapy for Deep Valve Incompetence: Adapted from Chapter 42 of the “Handbook of Venous Disorders”. Original author: Seshadri Raju. Abstracted by Gary W. Lemmon.
  18. Iliac and Vena Cava Obstructive Venous Disease Therapy: Adapted from Chapter 44 of the “Handbook of Venous Disorders”. Original author: Peter Neglén. Abstracted by Gary W. Lemmon.
  19. Vascular Malformations: Adapted from Chapters 53, 54 and 55 of the “Handbook of Venous Disorders”. Original authors: for Chapter 53 – Byung Boong Lee, James Loredo, David H. Deaton, Richard F. Neville; for Chapter 54 and 55 – Heron E. Rodriguez and William H. Pearce. Abstracted by Raghu Motaganahalli.
  20. Lymphedema Diagnosis and Therapy: Adapted from Chapters 57, 59 & 60 of the “Handbook of Venous Disorders”. Original authors: for Chapter 57 -Thom W. Rooke, Cindy Felty; for Chapter 59 – Gail L. Gamble, Audrea Cheville, David Strick; and for Chapter 60 – Peter Gloviczki. Abstracted by Raghu Motaganahalli.